ARCHIVES

Wyden Asks Bristol For documentation To Prove That Taxol Price Is Not “Gouging” Taxpayers

This article is from The Cancer Letter archive.

Vol. 19 No. 05 | January 29, 1993

Download PDF Visit The Full Archive

Related Articles

Advisors Suggest Consortia For Lung Cancer Research.

November 9, 2001

With A Flat Budget, Niederhuber Outlines NCI Priorities In Speech To ASCO Meeting.

June 13, 2008

Concepts for New, Recompeted DCCP Contracts Approved

June 12, 1981

Drug Company Cries Foul Over Clams Of Taxotere’s Superiority To Taxol

June 11, 1993

SAIC Frederick Offers Use Of Drug Facility

August 4, 1995

Physician Bonus Denied Some Agencies; NIH Status Unsure

January 18, 1991